Catalyst Wire Dossier Catalyst Wire Dossier

subcutaneous immunotherapy treatment for Olea europaea pollen

· Laboratorios Leti, S.L.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for subcutaneous immunotherapy treatment for Olea europaea pollen, covering 2018-02-23 to 2018-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Olea Europaea Pollen [Phase 3]

See pricing